BioPharma Pharma Research

Singular Genomics Commercially Launches G4X to Scale Spatial Multiomics for Precision Medicine

 Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, announced the commercial launch...

 February 24, 2026 | News

NEXT Life Sciences Advances Two Non Hormonal Male Contraceptives Into Phase II Trials

Men have long been waiting for new male contraceptive options outside of just condoms and vasectomy. Non-hormonal methods at the forefront of male interest...

 February 23, 2026 | News

Asahi Kasei Pharma Advances AK1960 Into Phase I For Refractory Kidney Diseases

Asahi Kasei Pharma, a global provider of healthcare and pharmaceutical solutions, in collaboration with Alchemedicine, has announced that its novel Endothe...

 February 23, 2026 | News

Thermo Fisher Scientific Launches Sequential Protein DNA RNA Extraction Kit To Enable Multiomic Analysis From A Single Sample

Thermo Fisher Scientific has introduced the Thermo Scientific Sequential Protein DNA RNA Extraction Kit, a sample preparation solution desi...

 February 20, 2026 | News

Bon Natural Life Establishes Joint Laboratory To Advance Bio Manufactured Natural Ingredients

Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, anno...

 February 19, 2026 | News

Waters Introduces 1 mm I.D. Microflow LC Columns With MaxPeak Premier Technology

Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput...

 February 19, 2026 | News

Omics Empower Expands Spatial Transcriptomics Services With Xenium Platform In Hong Kong

Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In S...

 February 16, 2026 | News

Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...

 February 16, 2026 | News

Syngene Partners With Johns Hopkins To Accelerate Early Stage Drug Discovery

Syngene International, a global contract research, development, and manufacturing organization (CRDMO) announced a strategic collaboration with Johns Hopki...

 February 13, 2026 | News

Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH

Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure")  announced that they have entere...

 February 13, 2026 | News

WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...

 February 13, 2026 | News

GCCL And Medicover Integrated Clinical Services Sign MOU To Strengthen Multinational Trial Delivery

GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an internation...

 February 12, 2026 | News

Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104

 Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...

 February 09, 2026 | News

PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly

Zonsen PepLib Biotech Inc. (“PepLib”) announced that it has entered a global research and development (R&D) collaboration and license agree...

 February 06, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close